Banner - NPPA Connect
Logo Image
|Poll|October 3, 2022

POLL: Which September FDA Approval Were You Most Excited About?

Click here to answer this week's poll.

Which September FDA Approval Were You Most Excited About?

Dupilumab for prurigo nodularis
Deucravacitinib for psoriasis
DaxibotulinumtoxinA for glabellar lines
Spesolimab for generalized pustular psoriasis

Related Content

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes
Adaptive Learning

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

View more